Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-26 12:56 pm Purchase |
2021-08-16 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 1,305,200 13.600% |
1,305,200 (New Position) |
Filing History |
| 2021-06-01 4:02 pm Purchase |
2021-05-20 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 720,373 8.500% |
248,679 (+52.72%) |
Filing History |
| 2021-05-10 4:04 pm Purchase |
2021-04-29 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 471,694 6.500% |
471,694 (New Position) |
Filing History |
| 2021-03-15 4:38 pm Purchase |
2021-03-10 | 13G | Viridian Therapeutics, Inc. VRDN |
RA Capital Management, L.P. | 388,385 6.300% |
388,385 (New Position) |
Filing History |
| 2021-03-10 07:17 am Purchase |
2021-02-26 | 13G | Viridian Therapeutics, Inc. VRDN |
Wellington Management Group LLP | 578,560 11.100% |
578,560 (New Position) |
Filing History |
| 2021-02-19 08:02 am Purchase |
2021-02-09 | 13G | Viridian Therapeutics, Inc. VRDN |
Hawkes Bay Master Investors (Cayman) L.P. | 363,284 6.970% |
363,284 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Citadel Advisors LLC | 427,218 9.900% |
656 (+0.15%) |
Filing History |
| 2021-02-16 3:09 pm Purchase |
2020-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Point72 Asset Management, L.P. | 426,162 10.900% |
426,162 (New Position) |
Filing History |
| 2021-01-19 4:18 pm Purchase |
2021-01-07 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Cormorant Asset Management LP | 459,144 9.990% |
459,144 (New Position) |
Filing History |
| 2021-01-11 4:08 pm Purchase |
2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Citadel Advisors LLC | 426,562 9.900% |
426,562 (New Position) |
Filing History |
| 2021-01-11 12:07 pm Purchase |
2020-12-16 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Xencor Inc XNCR |
322,407 7.600% |
322,407 (New Position) |
Filing History |
| 2021-01-07 07:36 am Purchase |
2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Ally Bridge MedAlpha Master Fund L.P. | 929,979 9.990% |
929,979 (New Position) |
Filing History |
| 2021-01-05 06:04 am Purchase |
2021-12-31 | 13D | MIRAGEN THERAPEUTICS INC MGEN |
Fairmount Funds Management LLC | 967,671 19.990% |
967,671 (New Position) |
Filing History |
| 2020-12-17 4:40 pm Purchase |
2020-12-07 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
RA Capital Management, L.P. | 451,932 11.600% |
451,932 (New Position) |
Filing History |
| 2020-11-16 4:04 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Logos Global Management LP | 550,000 14.100% |
550,000 (New Position) |
Filing History |
| 2020-11-10 10:27 am Sale |
2020-11-09 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
FMR LLC | 0 0.000% |
-2,888,656 (Position Closed) |
Filing History |
| 2020-11-09 5:26 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
BIOTECHNOLOGY VALUE FUND L P | 7,584,219 9.990% |
7,584,219 (New Position) |
Filing History |
| 2020-11-09 12:26 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Logos Global Management LP | 6,000,000 8.800% |
6,000,000 (New Position) |
Filing History |
| 2020-10-29 4:51 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Point72 Asset Management, L.P. | 6,500,000 9.500% |
6,500,000 (New Position) |
Filing History |